GlaxoSmithKline PLCGSK:LSE

1,464.5
14.00 / 0.97%
7.39m
10.21 %
0.4661
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of May 22 2015 17:08 BST.
See more company Information on this page. Log in or Register for free now
In millions of GBP (except for per share items)
Fiscal data as of Dec 31 2014201420132012
OPERATIONS
Net income2,8315,6284,678
Depreciation/depletion780732871
Non-Cash items1,2121,1902,253
Cash taxes paid, supplemental1,1081,2771,673
Cash interest paid, supplemental707749779
Changes in working capital(351)(1,010)(4,001)
Total cash from operations5,1767,2224,375
INVESTING
Capital expenditures(1,751)(1,701)(1,520)
Other investing and cash flow items, total6732,225(1,111)
Total cash from investing(1,078)524(2,631)
FINANCING
Financing cash flow items(1,699)(1,684)(1,037)
Total cash dividends paid(3,843)(3,680)(3,814)
Issuance (retirement) of stock, net(71)(919)(2,079)
Issuance (retirement) of debt, net22810.003,579
Total cash from financing(5,385)(6,273)(3,351)
NET CHANGE IN CASH
Foreign exchange effects84(148)(92)
Net change in cash(1,203)1,325(1,699)
Net cash-begin balance/reserved for future use5,2313,9065,605
Net cash-end balance/reserved for future use4,0285,2313,906
SUPPLEMENTAL INCOME
Depreciation, supplemental780732871
Cash interest paid, supplemental707749779
Cash taxes paid, supplemental1,1081,2771,673
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.